1¿ù 16ÀÏ ¸ñ¿äÀÏ
¾ÆÀ̵ð
ºñ¹Ð¹øÈ£
¾ÆÀ̵ð ã±â
Ƽ¼ÅÃ÷ (¹ÝÆÈ)
Ƽ¼ÅÃ÷ (±äÆÈ)
Ä¿Ç÷è (ÇÒÀÎ)
Á¡ÆÛ(ÆǸŸ¶°¨)
Ư°¡ÆǸŠ<==ÁøÇàÁß
ºþ¦¼¼ÀÏ
-Ä«µå°áÁ¦¿ë-
Home
> ¹®ÀÇ °Ô½ÃÆÇ ¼öÁ¤
°³ÀÎÁ¤º¸ À¯ÃâÀ» ¹æÁöÇϱâ À§ÇÏ¿© E-Mail°ú ÀüȹøÈ£´Â ÇØ´ç¶õ¿¡ ±âÀçÇÏ¿© ÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù.
À̸§
*
*
´Â ¹Ýµå½Ã ÀÔ·ÂÇØ ÁֽʽÿÀ.
Æнº¿öµå
*
¼öÁ¤, »èÁ¦½Ã¿¡ ÇÊ¿äÇÕ´Ï´Ù.
E-Mail
*
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
ÀüȹøÈ£
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
Á¦¸ñ
*
³»¿ë
*
I'm not interested in football
atorvastatin patent expiry uk
Statements made on this call today include forward-looking statements, such as those with the words will, believes, expects, continues and similar phrases that denote future expectation or intent regarding our financial outlook, product offerings, customer demand and other matters. These statements are based on the environment as we currently see it and are subject to risks and uncertainties. Please refer to the press release and the risk factors and documents filed with the Securities and Exchange Commission, including our most recent reports on Form 10-Q and Form 10-K for information on risks and uncertainties that may cause actual results to differ materially from those set forth in such statements.
¸ñ·Ï
»ç¾÷ÀÚµî·Ï¹øÈ£: 607-10-79364 ºÎ°¡Åë½Å»ç¾÷½Å°í : ºÎ»ê Á¦ 455È£
Copyright (C) 2001 Å©¸®¿¡ÀÌƼºê µðÁöÅÐ All rights reserved.